Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Forman

Showing results (421-430 of 504) with videos related to

Pageof 51
Sort By:
Transplantation and Cellular Therapy|April 10, 2022
Total Marrow and Lymphoid Irradiation with Post-Transplantation Cyclophosphamide for Patients with AML in RemissionAnthony S Stein, Monzr M Al Malki, Dongyun Yang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 4, 2023
Association Between Pretreatment Skeletal Muscle and Outcomes After CAR T-Cell TherapyKyuwan Lee, Aleksi Iukuridze, Tianhui He, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2006
A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remissionDavid I Marks, Stephen J Forman, Karl G Blume, et al.
Journal of Hematology & Oncology|August 14, 2024
IL1RAP-specific T cell engager depletes acute myeloid leukemia stem cellsYi Zhang, Miso Park, Lucy Y Ghoda, et al.
JACC. Cardiooncology|February 3, 2025
Clonal Hematopoiesis and Risk of Heart Failure After Autologous Hematopoietic Cell Transplantation for LymphomaJune-Wha Rhee, Raju Pillai, Sitong Chen, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targetingEric Hee Jun Lee, Cody Cullen, John P Murad, et al.
Molecular Therapy. Methods & Clinical Development|May 16, 2022
Pre-clinical data supporting immunotherapy for HIV using CMV-HIV-specific CAR T cells with CMV vaccineMin Guan, Laura Lim, Leo Holguin, et al.
Nature Biomedical Engineering|October 1, 2025
Solid tumour CAR-T cells engineered with fusion proteins targeting PD-L1 for localized IL-12 deliveryJohn P Murad, Lea Christian, Reginaldo Rosa, et al.
Transplantation and Cellular Therapy|August 5, 2024
Lower Weight-Based Mycophenolate Mofetil Dosing is Associated with Superior Outcomes after Haploidentical Hematopoietic Cell Transplant with Post-transplant CyclophosphamideHany Elmariah, Salman Otoukesh, Ambuj Kumar, et al.
Cell Stem Cell|April 8, 2022
3D-organoid culture supports differentiation of human CAR<sup>+</sup> iPSCs into highly functional CAR T cellsZhiqiang Wang, Helen P McWilliams-Koeppen, Hernan Reza, et al.
Pageof 51

Showing results (421-430 of 504) with videos related to

Sort By:
Pageof 51
Transplantation and Cellular Therapy|April 10, 2022
Total Marrow and Lymphoid Irradiation with Post-Transplantation Cyclophosphamide for Patients with AML in RemissionAnthony S Stein, Monzr M Al Malki, Dongyun Yang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 4, 2023
Association Between Pretreatment Skeletal Muscle and Outcomes After CAR T-Cell TherapyKyuwan Lee, Aleksi Iukuridze, Tianhui He, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2006
A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remissionDavid I Marks, Stephen J Forman, Karl G Blume, et al.
Journal of Hematology & Oncology|August 14, 2024
IL1RAP-specific T cell engager depletes acute myeloid leukemia stem cellsYi Zhang, Miso Park, Lucy Y Ghoda, et al.
JACC. Cardiooncology|February 3, 2025
Clonal Hematopoiesis and Risk of Heart Failure After Autologous Hematopoietic Cell Transplantation for LymphomaJune-Wha Rhee, Raju Pillai, Sitong Chen, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targetingEric Hee Jun Lee, Cody Cullen, John P Murad, et al.
Molecular Therapy. Methods & Clinical Development|May 16, 2022
Pre-clinical data supporting immunotherapy for HIV using CMV-HIV-specific CAR T cells with CMV vaccineMin Guan, Laura Lim, Leo Holguin, et al.
Nature Biomedical Engineering|October 1, 2025
Solid tumour CAR-T cells engineered with fusion proteins targeting PD-L1 for localized IL-12 deliveryJohn P Murad, Lea Christian, Reginaldo Rosa, et al.
Transplantation and Cellular Therapy|August 5, 2024
Lower Weight-Based Mycophenolate Mofetil Dosing is Associated with Superior Outcomes after Haploidentical Hematopoietic Cell Transplant with Post-transplant CyclophosphamideHany Elmariah, Salman Otoukesh, Ambuj Kumar, et al.
Cell Stem Cell|April 8, 2022
3D-organoid culture supports differentiation of human CAR<sup>+</sup> iPSCs into highly functional CAR T cellsZhiqiang Wang, Helen P McWilliams-Koeppen, Hernan Reza, et al.
Pageof 51